ESR1 and breast cancer: Hormonal and HER2 status distributions should be also carefully evaluated to check whether they are representative of the typical BC heterogeneity, as we did for TCGA and GSE96058 datasets using ER/PR/HER2 proportions found in the literature as benchmark24.